Tetromycin B
Tetromycin B is a cysteine protease inhibitor with Ki values of 0.62, 1.42, 32.5, and 1.59 μM for rhodesain, falcipain-2, cathepsin L, and cathepsin B, respectively. It inhibits the growth of T. brucei in vitro (IC50=30.87 μM) . Tetromycin B is also cytotoxic to HEK293T kidney cells and J774.1 macrophages (IC50s=71.77 and 20.2 μM, respectively) .
Product Specifications
CAS Number
[180027-84-3]
UNSPSC
12352005
Target
Parasite
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Smiles
CC1=C[C@]2([C@@]([H])([C@H](CC[C@@H]2O)C)[C@@](C)([C@@]1(/C(C)=C/CC/C(C)=C/[C@]3([C@]4(C[C@H](C(C)=C3)C)OC5=O)C)[H])C(C5=C4O)=O)[H]
Molecular Formula
C34H46O5
Molecular Weight
534.73
References & Citations
[1]Pimentel-Elardo, et al. New tetromycin derivatives with anti-trypanosomal and protease inhibitory activities. Mar. Drugs 9 (10), 1682-1697 (2011) .
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
APC/CY7-Linked Polyclonal Antibody to Cholinergic Receptor, Nicotinic, Alpha 2 (CHRNa2)
APC/CY7-Linked Polyclonal Antibody to Cholinergic Receptor, Nicotinic, Alpha 2 (CHRNa2)
APC/CY7-Linked Polyclonal Antibody to Cholinergic Receptor, Nicotinic, Alpha 2 (CHRNa2)
APC/CY7-Linked Polyclonal Antibody to Cholinergic Receptor, Nicotinic, Alpha 2 (CHRNa2)
APC/CY7-Linked Polyclonal Antibody to Cholinergic Receptor, Nicotinic, Alpha 2 (CHRNa2)